Invention Grant
US08735595B2 Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome
有权
乙酰辅酶A羧化酶（ACC）抑制剂及其在糖尿病，肥胖症和代谢综合征中的应用
- Patent Title: Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome
- Patent Title (中): 乙酰辅酶A羧化酶（ACC）抑制剂及其在糖尿病，肥胖症和代谢综合征中的应用
-
Application No.: US11675406Application Date: 2007-02-15
-
Publication No.: US08735595B2Publication Date: 2014-05-27
- Inventor: Yu Gui Gu , Xiangdong Xu , Moshe Weitzberg , Hing L. Sham
- Applicant: Yu Gui Gu , Xiangdong Xu , Moshe Weitzberg , Hing L. Sham
- Applicant Address: US IL North Chicago
- Assignee: AbbVie Inc.
- Current Assignee: AbbVie Inc.
- Current Assignee Address: US IL North Chicago
- Agency: Michael Best & Friedrich LLP
- Agent Lisa V. Mueller
- Main IPC: A61K31/4439
- IPC: A61K31/4439 ; A61K31/426 ; C07D417/04 ; C07D277/34
Abstract:
The present invention relates to compounds of formula (I) which inhibit acetyl-CoA carboxylase (ACC) and are useful for the prevention or treatment of metabolic syndrome, type II diabetes, obesity, atherosclerosis and cardiovascular diseases in humans.
Public/Granted literature
- US20070219251A1 NOVEL ACETYL-COA CARBOXYLASE (ACC) INHIBITORS AND THEIR USE IN DIABETES, OBESITY AND METABOLIC SYNDROME Public/Granted day:2007-09-20
Information query
IPC分类:
